A multicentre randomised and comparative trial to assess the tolerance, efficacy and pharmacokinetics of escalating doses of Casodex versus castration in the treatment of advanced carcinoma of the prostate

Trial Profile

A multicentre randomised and comparative trial to assess the tolerance, efficacy and pharmacokinetics of escalating doses of Casodex versus castration in the treatment of advanced carcinoma of the prostate

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Sep 2006

At a glance

  • Drugs Bicalutamide; Goserelin
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 Sep 2006 Status change
    • 29 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top